GLP1-RA are also contraindicated in patients with a personal or family history of medullary thyroid cancer and in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) as they have been shown to cause thyroid C-cell tumors in rodents (56, 57). This evidence concerns the gene GCG and medullary thyroid gland carcinoma.